Big Health, LLC – Trademark Portfolio
Entity Type: 16
Big Health, LLC holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 17 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include BUSTMAXX, TESTOVOX, CLEARZINE, CURVINEXX, and URTHGREENS. The owner is based in Brodheadsville, PA.
PO Box 1302
Brodheadsville, PA 19322
Showing of trademarks Trademarks
Trademark Classifications
Big Health, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Big Health, LLC have?
Big Health, LLC has 21 U.S. trademarks filed with the USPTO. Of these, 11 registered, 6 abandoned, 4 cancelled.
What trademark classes does Big Health, LLC file in?
Big Health, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Big Health, LLC's most well-known trademarks?
Big Health, LLC's registered trademark portfolio includes well-known marks such as BUSTMAXX, TESTOVOX, CLEARZINE, CURVINEXX, and URTHGREENS. These are among 11 currently registered trademarks in the portfolio.
What is Big Health, LLC's trademark registration success rate?
Big Health, LLC has a 52% trademark registration rate, with 11 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.